Compare Adaptive Biotechnologies Corp (ADPT) vs GraniteShares 2x Long COIN Daily ETF (CONL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs GraniteShares 2x Long COIN Daily ETF — how do they compare? Adaptive Biotechnologies Corp trades at $20.06 (market cap $3.33B), while GraniteShares 2x Long COIN Daily ETF trades at $4.99. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| ADPT | CONL | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $22.37 | $64.57 |
52-Week Low | $10.24 | $4.09 |
Enterprise Value | $3.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
CONL trades at $5.62, up 4.07% today but remains a highly volatile leveraged ETF tracking Coinbase stock. Technical indicators show bearish momentum with mixed oscillators, while financial ratios are unavailable for this derivative product. Recent news highlights extreme volatility, with the fund losing 67% year-to-date as daily reset leverage magnifies Coinbase price swings.
The outlook remains speculative with potential for explosive gains if Coinbase rallies, but structural risks from daily leverage reset create significant volatility decay. Investors face amplified exposure to cryptocurrency market sentiment and Coinbase performance without traditional company fundamentals to anchor valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →
